Skip to content
Home
Search
About
Disclaimer
Contact
WhatMyPillDoes
Home
Search
About
Disclaimer
Contact
Important:
This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does
not
mean the drug caused the event.
Full disclaimer
.
Home
Second primary malignancy
All Drugs
All Drugs Associated with Second primary malignancy (Page 4)
237 drugs have been associated with
Second primary malignancy
in FAERS reports.
Drug
Reports
Deaths
Hosp.
Life-Threat.
ABEMACICLIB
12
3
8
1
FLUOROURACIL\LEUCOVORIN\OXALIPLATIN
12
0
0
0
TEMOZOLOMIDE
12
1
2
0
INVESTIGATIONAL PRODUCT
11
1
4
0
SANDOSTATIN LAR
11
4
8
1
TAFASITAMAB
11
0
2
1
CORTISONE
10
10
9
0
DARATUMUMAB
10
2
3
2
ELRANATAMAB
10
2
4
2
GLEEVEC
10
1
2
0
GOSERELIN
10
0
6
0
IDELALISIB
10
2
2
1
MITOMYCIN
10
8
0
0
PLATINUM
10
6
0
0
BLINATUMOMAB
9
4
3
0
CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE
9
2
0
1
ENFORTUMAB VEDOTIN-EJFV
9
0
1
4
FUROSEMIDE
9
1
8
0
HYDROMORPHONE
9
1
8
0
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
9
2
0
6
LENVATINIB
9
1
2
0
PEGFILGRASTIM
9
2
5
0
WARFARIN
9
1
7
0
ACALABRUTINIB
8
1
1
0
INTERFERON ALFA-2A OR INTERFERON ALFA-2B
8
5
0
0
LOSARTAN
8
2
6
1
NEDAPLATIN
8
5
0
0
NIRAPARIB
8
1
3
6
PANITUMUMAB
8
3
0
0
PIRARUBICIN
8
2
0
0
TOCILIZUMAB
8
2
1
1
ABIRATERONE
7
0
1
2
ADALIMUMAB
7
1
6
1
ASCIMINIB
7
1
3
1
CYANOCOBALAMIN
7
0
7
0
ELRANATAMAB-BCMM
7
1
2
2
ESTRAMUSTINE
7
1
0
0
EZETIMIBE
7
0
7
0
LANSOPRAZOLE
7
2
5
0
MASITINIB
7
5
0
0
SERTRALINE
7
0
1
2
SOMATROPIN
7
1
0
1
TENIPOSIDE
7
5
2
0
VEMURAFENIB
7
0
2
1
ZOPICLONE
7
0
7
0
AMSACRINE
6
4
1
1
CANDESARTAN CILEXETIL
6
0
6
0
DACOMITINIB
6
1
1
1
DICLOFENAC
6
4
3
0
FEDRATINIB
6
5
0
0
«
1
2
3
4
5
»